Detalhe da pesquisa
1.
Effect of nusinersen on motor, respiratory and bulbar function in early-onset spinal muscular atrophy.
Brain
; 146(2): 668-677, 2023 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35857854
2.
Abrasion arthroplasty increases mesenchymal stem cell content of postoperative joint effusions.
BMC Musculoskelet Disord
; 16: 250, 2015 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26364138
3.
Improvements in Walking Distance during Nusinersen Treatment - A Prospective 3-year SMArtCARE Registry Study.
J Neuromuscul Dis
; 10(1): 29-40, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36565133
4.
Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study.
Orphanet J Rare Dis
; 17(1): 384, 2022 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36274155
5.
SMArtCARE - A platform to collect real-life outcome data of patients with spinal muscular atrophy.
Orphanet J Rare Dis
; 14(1): 18, 2019 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30665421
6.
Evaluation of Children with SMA Type 1 Under Treatment with Nusinersen within the Expanded Access Program in Germany.
J Neuromuscul Dis
; 5(2): 135-143, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29689734
7.
Validation of the Gross Motor Function Measure for use in children and adolescents with traumatic brain injuries.
Pediatrics
; 120(4): e880-6, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17908744